The Best Way to Wean Off Wegovy: What to Consider Before You Stop

Wegovy (semaglutide) is a prescription-only medicine; stopping, reducing or changing the schedule is a clinical decision, not a personal one to make without guidance.
Appetite and weight can return relatively quickly after stopping, particularly if lifestyle changes are not firmly established — this is well documented in the clinical evidence.
There is no single licensed tapering schedule: your prescriber weighs up your dose history, your tolerance, your reason for stopping and your next steps.
The Patient Information Leaflet that comes with your Wegovy pen is your most precise reference for what to do if you miss a dose or are considering stopping.

Weaning off Wegovy is not a one-size-fits-all process, and the right way to do it depends heavily on why you are stopping. There is no universally mandated tapering protocol in the Wegovy licence — the prescriber who manages your treatment is the right person to guide the pace, because they know your dose history, how you have responded, and what happens next for your weight management. As a prescription-only medicine, any change to how you take semaglutide should be agreed with your clinical team rather than decided independently. This page walks through the factors that shape the decision so you can have an informed conversation.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What actually shapes the decision to reduce or stop Wegovy, and how to do it safely

Start with the reason you want to stop

The single biggest factor in how to approach coming off Wegovy is the reason behind the decision. These are genuinely different situations that call for different responses. A planned stop because you have reached your weight goal and feel ready to maintain it independently is very different from stopping because of side effects, or because supply has become an issue, or because you are preparing for surgery.

If side effects are driving the decision, your prescriber might first consider whether staying at a lower dose for longer resolves the problem rather than stopping altogether. Many people find the dose escalation is where nausea or fatigue is most disruptive; dropping back a step is sometimes all that is needed. Our page on managing your experience on Wegovy covers practical strategies for the common side effects that come up during titration.

If you are stopping because you feel you have done the work and want to transition off, a gradual reduction is generally better tolerated than an abrupt halt at a high maintenance dose, though the pace depends on where you are in treatment. Talk through the plan with your prescriber before the next pen rather than after you have already stopped.

For surgical preparation, NHS England's guidance on weight-management injections advises telling your anaesthetist and surgical team that you are taking a GLP-1 medicine; your prescriber will advise on timing for pausing treatment around any procedure.

What the evidence says about stopping semaglutide

A question our prescribers hear most weeks is whether the weight lost will stay off once treatment ends. The honest answer from the clinical data is that it tends not to, without significant lifestyle support in place. The STEP 1 extension study, published in the New England Journal of Medicine, followed participants who stopped 2.4 mg semaglutide after 68 weeks and found that a substantial proportion of the weight lost was regained over the following year. That is not a reason to stay on treatment indefinitely when it is no longer appropriate, but it is a reason to treat the stopping period as a transition, not an endpoint.

This evidence matters for deciding how to wean off as much as whether to. Coming off more gradually can help you assess how your appetite and habits hold at each step, rather than facing an abrupt change in how hungry you feel. It also gives you and your prescriber time to identify early whether significant weight is returning in a way that warrants reconsidering the plan. If you are unsure whether you need to taper at all, our page on whether weaning off Wegovy is actually required for your situation is a good place to start before your clinical conversation. You can read more about the broader question of whether weaning is even necessary for your situation.

The NHS's patient guidance on semaglutide sets out what to do if you miss a dose or want to stop, and is a reliable starting point before your clinical conversation. Do not make changes based on forum advice or assumed protocols, the right taper for a person on 1.7 mg for eight weeks differs from one who has been on 2.4 mg for a year.

How the reduction itself is typically managed

Because Wegovy is titrated up in steps (0.25 mg through to the standard 2.4 mg maintenance dose, and up to 7.2 mg for those on the newer higher-dose pen), reducing it tends to work in reverse steps at a pace the prescriber sets. There is no fixed rule that mandates a specific number of weeks at each lower dose on the way down, this is where individual clinical judgement comes in.

Some people stop from a lower dose once they have already stepped back for a clinical reason, and find the transition manageable. Others stopping from a higher maintenance dose may benefit from a more deliberate step-down over several months. The practical process of weaning off Wegovy is covered in more detail in a dedicated page if you want to understand the mechanics further.

Lifestyle factors matter here too. Protein intake, regular meals and activity levels all influence how appetite regulation feels once the semaglutide is leaving your system. Your prescriber or a dietitian can help you put the right structure around the reduction period, this is not the time to also significantly restrict calories, since that compounds the adjustment your body is already making.

If cost has been a factor in the decision to stop and you have not yet reviewed your options, it is worth looking at what Wegovy pricing looks like across providers before assuming it is out of reach entirely. Some people find a lower maintenance dose is more affordable and still clinically appropriate for their stage.

When to get medical help

Stopping a GLP-1 medicine is generally safe when managed appropriately, but there are situations that warrant prompt contact with a clinician. If you experience persistent or severe nausea, vomiting or abdominal pain during or after reducing Wegovy, do not wait to see whether it passes. The MHRA highlighted acute pancreatitis as a known, infrequent but potentially serious side effect of GLP-1 medicines in a 2026 Drug Safety Update, severe stomach pain that spreads to the back, with or without vomiting, is a reason to seek urgent help rather than manage at home.

More broadly, if your weight is returning rapidly and you are struggling with appetite in a way that feels unmanageable, that is clinical information worth sharing with your prescriber early. There may be options (including returning to a lower dose, or exploring other evidence-based weight management approaches) that are better considered as a planned discussion than in a crisis.

You can report any suspected side effects through the MHRA's Yellow Card scheme, including effects experienced when stopping or reducing treatment.

If you have not yet started Wegovy and are researching it to understand the full picture, including stopping, our Wegovy treatment overview covers how the medicine works, what to expect on treatment and how private prescribing works in the UK. And if you would like to speak with a prescriber about whether Wegovy is still right for your situation, or whether stopping makes clinical sense for you now, check your eligibility with our clinical team, consultations are free and reviewed the same day by a GPhC-registered prescriber.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions